We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 27.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:1298O Marchpole Holdings PLC 30 July 2003 FOR IMMEDIATE RELEASE 30 JULY 2003 Marchpole Holdings plc (the 'Company') Director's shareholding The Company has been informed that Michael Morris has today sold 6,010,000 ordinary shares of 1 pence each in the Company ('Ordinary Shares'), representing 4.989 per cent of the issued share capital of the Company, to the Robert Lomnitz 2003 Trust. These Ordinary Shares represent the total interest of the Robert Lomnitz 2003 trust in the Company. Immediately following this disposal, Michael Morris is interested in 36,130,048 Ordinary Shares representing 29.995 per cent of the issued share capital of the Company. 30 July 2003 This information is provided by RNS The company news service from the London Stock Exchange END RDSEAFXEDLPDEFE
1 Year Mereo Biopharma Chart |
1 Month Mereo Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions